Zymographical techniques for detection of matrix metalloproteinases

Methods in Molecular Biology

Volumn 477, Issue , 2008, Pages 113-121

  Iwai, Shinichi ^b   Nakanishi Ueda, Takako ^b   Armstrong, Donald ^a,b,c   Oguchi, Katsuji ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b SHOWA UNIVERSITY   (Japan)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Matrix metalloproteinase; Plasma; Reverse zymography; Tissue inhibitors of metalloproteinase; Zymography

Indexed keywords

ENZYME PRECURSOR; GELATIN; MATRIX METALLOPROTEINASE;

ANALYSIS; ANIMAL; ARTICLE; BIOCHEMISTRY; BLOOD; ELECTROPHORESIS; ENZYME ACTIVATION; METABOLISM; METHODOLOGY; RAT; SPRAGUE DAWLEY RAT; STAINING;

ANALYTIC SAMPLE PREPARATION METHODS; ANIMALS; BIOCHEMISTRY; ELECTROPHORESIS; ENZYME ACTIVATION; ENZYME PRECURSORS; GELATIN; MATRIX METALLOPROTEINASES; RATS; RATS, SPRAGUE-DAWLEY; STAINING AND LABELING;

EID: 58149381142     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60327-517-0_10     Document Type: Article

References (23)

1. Nagase, H., and Woessner, J. F. (1999) Matrix metalloproteinases. J. Biol. Chem. 274, 21491-21494.
2. Kon, C. H., Occleston, N. L., Charteris, D., Daniels, J., Aylward, G. W., and Khaw, P. T. (1998) A prospective study of matrix metalloproteinases in proliferative vitreoretinapathy. Invest. Ophthalmol. Vis. Sci. 39, 1524-1529.
3. Kvanta, A., Sarman, S., Fagerholm, P., Seregard, S., and Steen, B. (2000) Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization. Exp. Eye Res. 70, 419-428.
4. Plantner, J. J., Jiang, C., and Smine, A. (1998) Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with age-related macular degeneration. Exp. Eye Res. 67, 637-645.
5. Chau, K. Y., Sivaprasad, S., Patel, N., Donaldson, T. A., Luthert, P. J., and Chong, N. V. (2008) Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye 22, 855-859.
6. Uemura, S., Matsushita, H., Li, W., Glassford, A. J., Asagami, T., Lee, K. H., Harrison, D. G., and Tsao P. S. (2001) Diabetes mellitus enhances vascular matrix metalloproteinase activity. Circ. Res. 88, 1291-1298.
7. Visse, R., and Nagase, H. (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92, 827-839.
8. Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., and Werb, Z. (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411-422.
9. Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., and Hanahan, D. (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2, 737-744.
10. Iwai, S., Aljada, A., Higa, A., Nakanishi-Ueda, T., Fukuda, S., Kamegawa, M., Iwabuchi, S., Ueda, T., Caballero, S., Browne, R., Afzal, A., Grant, M., Yasuhara, H., Koide, R., Oguchi, K., Dandona, P., and Armstrong, D. (2006) Activation of AP-1 and increased synthesis of MMP-9 in the rabbit retina induced by lipid hydroperoxide. Curr. Eye Res. 31, 337-346.
11. Brew, K., Dinakarpandian, D., and Nagase, H. (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochem. Biophys. Acta. 1477, 267-283.
12. Nagase, H., Visse, R., and Murphy, G. (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 69, 562-573.
13. Snoek-van Beurden, P. A., and Von den Hoff, J. W. (2005) Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors. BioTechniques 38, 73-83.
14. Heussen, C., and Dowdle, E. B. (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102, 196-202.
15. Fernández-Resa, P., Mira, E., Quesada, A. R. (1995) Enhanced detection of casein zymography of matrix metalloproteinases. Anal. Biochem. 224, 434-435.
16. Springman, E. B., Angleton, E. L., Birkedal-Hansen, H., and Van Wart, H. E. (1990) Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc. Natl. Acad. Sci. USA 87, 364-368.
17. Okamoto, T., Akuta, T., Tamura, F., van Der Vliet, A., and Akaike, T. (2004) Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation. Biol. Chem. 385, 997-1006.
18. Hawkes, S. P., Li, H., and Taniguchi, G. T. (2001) Zymography and reverse zymography for detecting MMPs, and TIMPs, in Matrix Metalloproteinase Protocols. (Clark, I. M., ed.), Humana, Totowa, NJ, pp. 399-410.
19. Woessner, J. F. Jr. (1995) Quantification of matrix metalloproteinases in tissue samples. Methods Enzymol. 248, 510-528.
20. Asano, Y., Iwai, S., Okazaki, M., Kumai, T., Munemasa, Y., Oonuma, S., Tadokoro, M., Kobayashi, S., and Oguchi, K. (2008) Matrix metalloproteinase-9 in spontaneously hypertensive hyperlipidemic rats. Pathophysiology In press.
21. Kamiya, Y., Iwai, S., Nara K., Okazaki, M., and Oguchi, K. (2005) Effects of green tea on matrix metalloproteinases in streptozotocin-induced diabetic rats. J. Clin. Biochem. Nutr. 37, 77-85.
22. Ogura, H., Nakanishi-Ueda, T., Ueda, T., Iwai, S., Uchida, S., Saito, Y., Taguchi, Y., Yasuhara, H., Armstrong, D., Oguchi, K., and Koide, R. (2007) Effect of a dihydrobenzofuran derivative on lipid hydroperoxide-induced rabbit corneal neovascularization. J. Pharmacol. Sci. 103, 234-240.
23. Vincenti, M. P. (2001) The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes, in Matrix Metalloproteinase Protocols. (Clark, I. M., ed.), Humana, Totowa, NJ, pp. 121-148.